Warning message

The following search keys are too short or too common and were therefore ignored: "si".
  1. Article | 2019.06.25

    Vector-pathogen interactions (4 entities)

    Vector-borne diseases play an increasing role among emerging infections. This thematic area explores the complex interactions between vectors and their pathogens, in order to identify ways of blocking infection of the vectors as a novel approach to epidemic control.

  2. Article | 2019.06.18

    Vectors

    The vectors, such as insects, are also investigated to develop new strategies to avoid microbes inoculation.

  3. Article | 2019.06.18

    Viruses

    Teams of the Department of Virology, of Global Heath, of Structural Biology and Chemistry and of Computational Biology study viruses causing infections to understand their epidemiology and to develop alternative strategies to fight them and overcome drug resistance.

  4. News | 2025.02.10

    Training Today’s and Tomorrow’s Scientists for the Challenges of Artificial Intelligence

    Artificial Intelligence (AI) is revolutionizing scientific research, particularly in the life sciences, by facilitating the processing of vast amounts of data and accelerating advancements in computational biology, genomics, and image analysis. Aware of this transformation, the Institut Pasteur has integrated AI into its projects from the outset and is further strengthening this commitment...

  5. Page avancée | 2016.09.20

    Education

    Education

  6. Vidéo | 2025.02.10

    The responsible behind sleeping sickness

    Dive into the heart of the trypanosome, the parasite responsible for sleeping sickness!Transmitted by the bite of the tsetse fly, this disease affects over 30 countries in sub-Saharan Africa. After infection, the first symptoms appear: fevers, anemia... But when the parasite invades the nervous system, it disrupts the sleep cycle, hence its name.Thanks to cutting-edge technology, Philippe Bastin...

  7. News | 2025.02.10

    The Institut Pasteur and AlterDiag announce the signature of a strategic partnership on research and development of next generation rapid diagnostic technologies

    Through this long-term strategic partnership agreement, the Institut Pasteur and AlterDiag will carry out research and development projects to develop new single-domain antibodies (VHH) -based rapid diagnostic tests using lateral flow immunochromatography, with the aim of strengthening the fight against infectious diseases. Scientific and technological collaboration to meet global health...

  8. Vidéo | 2025.02.11

    When middle-schoolers speak out on research!

    Between December 16 and 20, the Institut Pasteur opened its doors to 60 middle-school students for their internship. For five days, they discovered research from the inside: meetings with scientists, laboratory experiments and immersion in fascinating fields such as microbiology and genetics. In this video, it's all about the trainees!Using a question-and-answer format, they share in their own...

  9. Document de presse | 2025.01.27

    The microbiota, an ally for predicting individual sensitivity to food additives

    Widely used by the food industry, emulsifiers – a type of food additive – are found in many daily foods (sliced bread, ice creams, crème fraîche, plant milks, etc.). Given their omnipresence in our diet, the health effects of their consumption have become a real public health issue. Benoit Chassaing, Inserm Research Director and leader of the Microbiome-Host Interactions team at Institut...

  10. Document de presse | 2025.02.12

    Mpox: a better understanding of tecovirimat resistance

    A virus originally found in animals, mpox – which causes the disease of the same name – is now circulating in humans. Since 2022, it has been the cause of major epidemics spreading outside endemic areas in Central and West Africa. Two hundred and fifteen cases of mpox infection were reported to Santé publique France in 2024. Tecovirimat is the drug most commonly used to treat patients infected...

Pages

Back to top